Alex Pretti from his early days working at the VA
Alex from our time working together, while he was in nursing school. Later, he moved to ICU, working as a nurse to support critically ill Veterans. He had such a great attitude. We’d chat between patients about trying to get in a mountain bike ride together. Will never happen now
Alex Pretti was a colleague at the VA. We hired him to recruit for our trial. He became an ICU nurse- I lover working with him. He was a good kind person who lived to help and these fuckers executed him.
White. Hot. Rage.
We lost someone extraordinary: Ethan Neumann, a PhD candidate in my lab, worked tirelessly to study fibrolamellar carcinoma - the cancer that would ultimately claim his life
Just before his died, he officially earned his doctorate and became Dr. Neumann
→ myarchoan.wixsite.com/yarchoanlabs...
Celebrating excellence in hepatology! 🌟
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
If you take care of patients with #HCC, do not miss this new update from BCLC
#liversky
@easlnews.bsky.social
www.journal-of-hepatology.eu/article/S016....
What did the largest trial of an early detection of cancer blood test show?
erictopol.substack.com/p/the-larges...
Richard Finn presents the results of phase 3 IMbrave152/SkYSCRAPER-14 study at #ESMO25
Anti-TIGIT tiragolumab does not add benefit to atezolizumab-bevacizumab for patients with advanced #HCC
#ESMOAmbassadors @myesmo.bsky.social
CARES-009 phase 3 study of perioperative camrelizumab and rivoceranib for #HCC
#ESMO25 #ESMOAmbassadors
@myesmo.bsky.social
Congratulations to AASLD’s newly elected 2026 SIG Steering Committee Leadership! Your enthusiasm, participation, and commitment to shaping AASLD were seen throughout the election process.
Learn more: https://www.aasld.org/2026-aasld-special-interest-group-sig-election-results
Withdrawing from the War on Cancer: an extraordinarily successful scientific research system that took decades to build, saved millions of lives and generated billions of dollars in profits is being dismantled in short order. @jonathanmahler.bsky.social www.nytimes.com/2025/09/14/m...
We are thrilled to announce the #AASLD 2025 Distinguished Award recipients! Join us in celebrating their achievements and commitment to #hepatology. Learn more about each recipient and their remarkable work: https://bit.ly/4giq0SS
A very comprehensive review on current state of HCC screening, diagnosis and treatment.
www.jhep-reports.eu/article/S258...
#Liversky
@easlnews.bsky.social
BREAKING: Gov. JB Pritzker says the Trump administration has sent the Texas National Guard to Great Lakes Naval Base outside Chicago, awaiting orders to deploy to Chicago.
Trump administration officials will target Mexican Independence Day (Sept. 16) celebrations. @wttw.bsky.social
The @fda.gov just approved @novonordisk.bsky.social #wegovy on an accelerated path for #MASH F2/F3 fibrosis
We now have 2 approved drugs with different MOA and that’s great news for patients. I anticipate at least 5 more approvals in the next 5 years.
#liversky
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
THIS IS HUGE! TWO Phase I HIV vaccine clinical trials have demonstrated that a stepwise mRNA-based vaccination strategy can SUCCESSFULLY activate AND advance immune responses toward producing broadly neutralizing antibodies (bnAbs), a CRITICAL milestone in HIV prevention. Let’s talk about that! 🧪🧵⬇️
We've greatly underestimated the role of the gut microbiome in fatty liver disease (MASLD). This open-access outstanding review @jclinical-invest.bsky.social is illuminating
www.jci.org/articles/vie...
📣UM Liver Cancer Diagnosis and Treatment CME Course on March 15th 2025 in Southfield, MI: in person and online. Featuring UM faculty and Dr. Laura Kulik from Northwestern University.
Registration here:
umich.cloud-cme.com/course/cours...
🔥Nivolumab and Ipilimuma approved by EMA for advanced hepatocellular carcinoma 🔥
👇https://ec.europa.eu/health/documents/community-register/html/h1014.htm
👉great news for our patients > more options in 1st line
😅amazing: approval in 🇪🇺by EMA before 🇺🇸by FDA
@myESMO @EASLedu @ILCAnews #livertwitter
How do we interpret and act on disparities in liver cancer outcomes ??
Expert editorial by @laurennephewmd.bsky.social
journals.lww.com/hepcomm/full...
#liversky
1/
The sickest patients are supposed to get priority for lifesaving transplants. But nearly 20% of the time, the American organ transplant system is skipping over hundreds or even thousands of people when it distributes kidneys, livers, lungs and hearts, a New York Times investigation found.
Every year I feel so fortunate to be part of this #LiverCancer community with these amazing friends who are true leaders sharing a common goal!! Amongst the beautiful chaos that is life, it’s important to find your passion and your people 💚. That’s a wrap @hcclive.bsky.social
Very sad news regarding Josh Levitsky. He was a seminal mentor for me and a great friend. He will be missed. Much love to his family and the Northwestern Transplant family.
Routine [18F]FCH and [18F]FDG PET-CT for tumour staging in all patients with a 1st diagnosis of hepatocellular carcinoma has limited clinical value
Guidelines should continue to emphasise morphological imaging (eg MRI & CT) for staging
#OncSky #MedSky @oncoalert.bsky.social @naultjc.bsky.social
This trial by @bloompringle.bsky.social will be seen as one of the most important in the field of FMT - 💩 transplant - for #cirrhosis
Does the 💩 engraft?
Does the 💩 work (improved barrier function)?
This is why PPB is the future
journals.lww.com/hepcomm/full...
#liversky
Great review of hemangiomas, FNH, & more by @renumathyd.bsky.social! I encourage all learners to read the classic imaging features.
✅️Review the imaging yourself
✅️Follow up if >5cm
✅️Biopsy for atypical appearance
journals.lww.com/hepcomm/fullte…
@jhepatology.bsky.social #Liversky #GITwitter
BREAKING: 22 states sue NIH over Trump administration's new 15% cap on overhead for federal research grants. Suit filed federal court in Boston contends lifesaving research 'will grind to a halt' under the policy. Doc: storage.courtlistener.com/recap/gov.us...
BREAKING: rifaximin and simvastatin did not help people with decompensated cirrhosis
Congratulations to Elisa Pose
And congrats to @jama.com for getting this paper
#liversky t.co/BuPL0mURhl
